Sign Up
Stories
Oncology Drugs Market Soars by 2030
Share
ADC Therapeutics Reports Financial Progr...
ADC Therapeutics Webcast Announced
Advancements in Lymphoma Treatments
Oncology Drugs Market Soars by 2030
Oncology Drugs Market Surge 2030
Overview
API
The global oncology drugs market is set to achieve a substantial CAGR of 11.53%, reaching $474.06 billion by 2030, driven by factors like increasing cancer cases and R&D investment. Major pharmaceutical companies are actively involved in mergers and acquisitions. Targeted therapy and injectables are prominent in the market, with North America taking the lead due to high cancer rates.
Ask a question
How might the increasing prevalence of tobacco use impact the growth of the oncology drugs market?
In what ways could the dominance of targeted therapy and injectables influence future treatment trends in oncology?
What implications do the significant merger and acquisition deals among pharmaceutical companies have on market dynamics and competition?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Oct 2029
Nov 2029
Dec 2029
Coverage
strat